Trisaq is a pharmaceutical company dedicated to reversing the progression of chronic kidney disease ("CKD"). The company's products eliminate or modulate molecular targets that are responsible for the destruction of the kidney's podocytes and
for the deterioration of the kidneys' filtering function. These targets were newly discovered by the company's founders, and their central role in CKD pathogenesis is by now generally accepted.

The Trisaq logo carries different messages: the initial letter "T" of the company is formed by using abstract kidney shapes that also remind of leaves referring to the natural approach of the company's mission. The used color green reflects nature - the grid pattern of the leave symbolizes a perfect kidney filtration process. The brown/grey of the lettering shows the technical and scientific competence of the company.

The founders see their outstanding products well presented with this unusual and brave logo.